Advances in mesoporous silica nanoparticles for targeted
stimuli-responsive drug delivery
Loading...
Official URL
Full text at PDC
Publication date
2015
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Informa Healthcare
Citations
Exportar
Citation
Abstract
Mesoporous silica nanoparticles (MSNPs)are one of the most promising inorganic drug delivery systems(DDSs). The design and development of tumour-targeted MSNPs with stimuli-responsive drug release capability aim at enhancing the efficiency and minimising the side effects of antitumour drugs for cancer therapy.